ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,288Medicare Part D Prescriptions Filled, Including Refills

Rank: 82 out of 633

$520K Total Retail Price of All Prescriptions

Rank: 89 out of 633

404 Patients Receiving at Least One Drug in Part D
86% Patients 65 Years and Older
48% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Nebraska
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

15% of this provider’s 404 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

12% of this provider’s 404 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
FUROSEMIDE 442 437* 60 1 6
SIMVASTATIN 404 383 84 2 3
OMEPRAZOLE 399 344 69 3 2
LEVOTHYROXINE SODIUM 394 345 68 4 1
WARFARIN SODIUM 320 300 41 5 7
POTASSIUM CHLORIDE 264 238 35 6 11
FENTANYL 240 209 36 S2 7 46
AMLODIPINE BESYLATE 215 190 30 8 4
METFORMIN HCL 193 175 34 9 10
HYDROCODONE-ACETAMINOPHEN 192 148 39 S3 10 8
ALLOPURINOL 184 184 31 11 25
METOPROLOL TARTRATE 181 176* 35 12 12
PREDNISONE 170 165* 29 13 36
ENALAPRIL MALEATE 169 151 36 14 42
LISINOPRIL 163 158* 31 15 5
POLYETHYLENE GLYCOL 3350 161 132 31 16 29
SERTRALINE HCL 158 158 11 17 19
ATORVASTATIN CALCIUM 153 148* 36 18 9
CIPROFLOXACIN HCL 153 138 84 18 75
SPIRONOLACTONE 150 137 20 20 44
LORAZEPAM 149 144* 32 B 21 37
GABAPENTIN 145 123 29 22 16
CARVEDILOL 124 124 21 23 18
TRAMADOL HCL 119 84 21 24 15
CLONAZEPAM 110 88 18 B 25 54
METOPROLOL SUCCINATE 104 99* 20 26 13
GLIPIZIDE 104 99* 18 26 82
METHOTREXATE 101 101 14 28 237
OXYCODONE-ACETAMINOPHEN 100 72 22 S2 29 90
CLOPIDOGREL 94 94 14 30 30
LANTUS SOLOSTAR 92 87* 19 31 91
LANTUS 85 85 12 32 53
FLUOXETINE HCL 83 63 14 33 78
DOXAZOSIN MESYLATE 83 78* 20 33 86
PAROXETINE HCL 81 81 14 35 74
OLANZAPINE 81 68 13 A 35 123
ATENOLOL 80 80 15 37 22
PRAMIPEXOLE DIHYDROCHLORIDE 76 <11 <11 38 155
LOSARTAN POTASSIUM 75 70* 18 39 17
GLYBURIDE 74 69* 15 R 40 118
ADVAIR DISKUS 73 73 11 41 51
BISOPROLOL FUMARATE 68 63* 15 42 88
SULFAMETHOXAZOLE-TRIMETHOPRIM 61 56* 22 43 87
QUETIAPINE FUMARATE 59 <11 <11 A 44 57
AMITRIPTYLINE HCL 59 <11 <11 R 44 71
TAMSULOSIN HCL 58 53* 15 46 24
SUCRALFATE 57 <11 <11 47 135
AZITHROMYCIN 55 50* 43 48 84
LEVETIRACETAM 55 <11 <11 48 152
CRESTOR 51 <11 <11 50 27
CITALOPRAM HBR 51 <11 <11 50 20
MORPHINE SULFATE 51 <11 <11 S2 50 255
DONEPEZIL HCL 51 <11 <11 50 33
HYDROCHLOROTHIAZIDE 51 51 11 50 14
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 1, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.